Sign in to view content

Relationship Between Number of Intermediate-Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the DERBY, OAKS, and FILLY Trials

Eleonora Lad, MD, PhD

Video
Published 2022

Related

Baseline Characteristics in the Phase 2 GOLDEN Study of IONIS-FB-LRx, an Investigational Antisense Oligonucleotide Designed to Treat AMD-Associated Geographic Atrophy
Glenn J. Jaffe, MD
Annual Meeting Talks
2022
Mitochondria-Targeted Drug Elamipretide for Treatment of Vision Loss in Dry AMD With Noncentral Geographic Atrophy
Scott W. Cousins, MD
Annual Meeting Talks
2019
Episode 5: Adding Dexamethasone Implant to Ranibizumab for Persistent DME with Dr. Raj Maturi
Keyvan Koushan, MD, FRCSC
Member Podcasts
2017

Category: AMD-Non-Neovascular

See more